The American Society of Clinical Oncology (ASCO) has released updated guidelines for neoadjuvant chemotherapy in newly diagnosed advanced ovarian cancer, introducing changes in patient selection and treatment strategies. The changes reflect emerging evidence on racial disparities, treatment outcomes, and quality of life considerations. The publication of the new guidance follows dramatic shifts in treatment patterns …
Read More
Policybanaoo.com No1 Insurance company in India